| Code |
| MRAT |
| Title |
| PT. Mustika Ratu Tbk |
| Address |
|
| Background |
The Company activities its manufacturing trading and distribution of traditional herbal and cosmetics. |
| Business cp product |
The Company activities its manufacturing trading and distribution of traditional herbal and cosmetics. |
| Subsidiary affiliation |
| Subsidiaries | Domicile | Business | % | | PT Mustika Ratubuana International | Jakarta | Distribution and trading | 99.97 | | PT Mustika Ratu (M) Sdn.Bhd. | Malaysia | Distribution and trading | 100 | | PT Paras Cantik Kenanga | Jakarta | Distribution and trading | 99.9 | | PT Mustika International Laboratories | Jakarta | Distribution and trading | 99 |
|
| Commissioners |
| President Commissioner | : Ir. Djoko Ramiadji, MSc | | | Commissioner | : Haryo Tedjo Baskoro, MBA | | | Independent Commissioner | : Prof. DR. F.G Winarno | | | | | | Per 04 Jul 2023 | | |
|
| Directors |
| President Director/Indp | : Ir. Bingar Egidius Situmorang | | | Director | : Jodi Andrea Suryokusumo, BCom, MCorpGov, CA (ICAA) | | | Director | : Kusuma Ida Anjani Bcom, Mbus, MAppFin | | | | | | Per 04 Jul 2023 | | |
|
| Underwriter |
|
| Share registrar |
|
| Share holders |
| Shareholders | Shares | % | | | | PT. Mustika Ratu Investama | 305002000 | 71.26 | | | | Faadhil Irshad Nasution | 23353300 | 5.46 | | | | Jodi Andrea Suryokusumo Bcom | 50000 | 0,01 | | | | Public | 99594700 | 23.27 | | | | | | | | | As of Nov 13, 2023 | | | | |
|
| History stocks |
Type of ListingDatePrice## of SharesTotal Listed Shares IPO @ Rp. 2,60027-Jul-199550027000000107000000 1:4 Stock Split02-Aug-2002125321000000428000000
|
| Other infos |
|
| Created date |
| 2023-11-17 13:38:43 |
| Revised date |
| 2023-11-17 13:38:43 |
| Finance |
2024,
2023,
2022,
2021,
2020,
2019,
2018,
2017,
2016,
2015,
2014,
2013,
| Financial Statetment Date |
| Fiscal Year Ends |
| Months Covered in Income St |
| |
| Summary Covered in Income St |
| Cash and Cash Equivalents |
| Receivables |
| Inventories |
| Current Assets |
| Fixed Assets |
| Other Assets |
| Non Current Assets |
| Total Assets |
| Current Liabilities |
| Longterm Liabilities |
| Total Liabilities |
| Authorized |
| Paid-up Capital |
| Par Value |
| Paid-up Capital Shares |
| Retained Earnings |
| Total Equity |
| Minority Interest |
| |
| Summary of Income Statement |
| Total Sales |
| Cost of Good Sold |
| Gross Profit |
| Operating Profit |
| Other Income |
| Earning Before Tax |
| Tax |
| Net Income |
| Close Price |
| |
| Per Share Data (Rp) |
| Eps (annualized) |
| Book Value |
| |
| Financial Ratios |
| Debt Equity Ratio (X) |
| Roa(%) |
| Roe(%) |
| Npm(%) |
| Opm(%) |
| Gross Profit Margin (%) |
| Total Assets Turnover |
| |
| Cash Flow |
| CF from Operation Activities |
| CF from Investing Activities |
| CF from Financing Activities |
| Net Increase in Cash & Cash Equivalent |
| Cash & Cash Equivalent at Beginning of the Year |
| Cash & Cash Equivalent at The End of the Year |
|
|